Pembrolizumab

Pediatric Oncology Exploring the Efficacy and Safety of Pembrolizumab in Relapsed and Refractory Pediatric Hodgkin’s Lymphoma: Insights from the KHCC Experience
Faiha Bazzeh • Esraa Badarin • Iyad Sultan
doi.org/10.69690/ODMJ-018-0425-1982